Top Trump Officials Pressured FDA to Back Failed Covid Treatment (2)

Advisers to former President Donald Trump pressed the FDA to reauthorize a drug as a Covid-19 treatment even after the agency said it lacked efficacy and posed safety concerns, according to a congressional report obtained by Bloomberg Law.

The report from the House Select Subcommittee on the Coronavirus Crisis argued that officials in the Trump White House “executed coordinated pressure campaigns” to influence actions at the Food and Drug Administration, including efforts to promote hydroxychloroquine.

Trump repeatedly touted the immunosuppressive drug, which the FDA initially authorized in March 2020 as a treatment for certain hospitalized Covid-19 patients. The agency revoked ...